CDNA vs TWST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

CDNA

37.0
AI Score
VS
TWST Wins

TWST

37.3
AI Score

Investment Advisor Scores

CDNA

37score
Recommendation
AVOID NEW MONEY

TWST

37score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric CDNA TWST Winner
Forward P/E 156.25 0 Tie
PEG Ratio -0.12 0 Tie
Revenue Growth 52.2% 23.2% CDNA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 37.0/100 37.3/100 TWST
Profit Margin 24.2% -31.7% CDNA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED TWST

Relative Price Performance (Last 90 Days)

CDNA 1M: +36.1% · 3M: +128.3% TWST 1M: +46.8% · 3M: +95.4%

Current Technical Phase

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81

RSI (14): 80.8 · Price: $66.66

TWST

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (22.2% over 20 days), RSI 75

RSI (14): 75.2 · Price: $193.88

Fundamentals Snapshot

Metric CDNA TWST
Market Cap — —
Forward P/E 51.3 -250.2
Trailing P/E 30.8 —
Revenue (TTM) — —
Revenue Growth 0.5% 0.2%
Gross Margin 0.7% 0.5%
Operating Margin 0.0% -0.3%
EPS 2.11 -2.16
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TWST is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.